[2015-05-22]
BIBLIOGRAFIA
CURSO EPROCAD.
Hipoglucemiantes.
- Mortality risk among sulfonylureas: a systemati review and network
meta-analysis. Simpson,
S y col. Lancet Diabetes Endocrinolog 3: 43, 2015.
- Possible adverse effects of SGLT” inhibitors on bone. Taylor, S y col.
The Lancet 3: 8, 2015.
- Metformin is associated with reduced risk of pancreatic cancer in
patients with type 2 diabetes mellitus: a systematic review and met-analysis.
Wang, Z y co. Diabetes research and clínica practice 101, 2014.
·
Effect of exenatide,
sitagliptin or glimepiride on beta cell secretory capacity in early type 2
diabetes . gudipaty, L y col. Diabetes Care 37: 2452, 2014.
·
Initial choice of oral
glucose lowering mediction for diabetes mellitus. A patient centered
comparative effectiveness study. Berkowitz, S y col. JAMA doc 10.10001, 2014.
·
Tratamiento
de la diabetes tipo 2 en el paciente anciano. Gomez Huelgas, R y col. Med Clin
(Barc) 140: 134; 2013.
·
Metfomin in patients with
type 2 diabetes and kidney disease. A Systematic review. Inzucchi, S y
col. JAMA 312: 2668, 2014.
Diabetes
secundarias:
- Glucocorticoid induced hyperglycemia. Perez, A y co. J of Diabetes 6: 9,
2014.
Complicaciones
agudas de la diabetes.
- Acid base problems in diabetic ketoacidosis. Karnel, K y col. N Engl J
Med 272: 546, 2015.
Currentr diagnosis and treatment of hyperglycemic emergencies. Corwell,
B y col. Emerg Med Cin N Am 32: 431, 2014.
Control
diabetes.
Complicaciones
crónicas de la diabetes.
- Polycystic ovary síndrome: update on diagnosis and treatmente. Setji, R y col. Amer J of Med
127: 912, 2014.
- The diagnosis and management of non alcoholic fatty liver disease:
practice guideline by the american association for the study of liver diseases,
american collegue of gastroenterology, and the american Gastroentreological
Association. Chalasani,
N y col. Hapatology 55: 20015, 2012.
- Treatment of Painful diabetic neuropathy. Javed, S y col. Ther Adv
Chronic Dis 6: 15, 2015.
- Diabetic kidney disease: a report from an ADA consensus conference. Tuttle, K y col. Diabetes Care
37: 2864, 2014.
·
Cilostazol for intermittent
claudiction. Bedenis, R y col. Cochrane database of sytematic reviews, issue
10, art No CD003748, 2014.
·
ESC Guidelines on diabetes,
prediabetes, and cardiovascular diseases developed in collaboration with the
EASD-Summary. Ryden, L y col. Diabets & vascular disease research 11:132,
2014.
·
Influence of dietary
approaches to stop hypertension (DASH) diet on blood pressures: a systemati
review and meta-analysis on randomized controlled trials. Sannei, P y col. Nutrition, Mteabolsim & Cardiovascular
diseases 24: 1253, 2014.
·
New treatment for diabetic
retinopathy. Das, A y col. Diabetes,
Obesity and Metabolism 17: 230, 2015.
·
Neuropathic pain:
principles of diagnosis and treatment. Gilron, I y col. Mayo Clin Proc 90: 532,
2015.
·
Are reactive oxygen species
still the basis for diabetic complications. Di Marco E y col. Clinical Sciences
129: 199 2015.
·
Diabetic Kidney Disease:
pathopysiology and therapeutic tarjets. Toth, S y col. Journal of Diabetes RESearch vol 2015,
article ID 697010.
Insulinoterapia.
Medidas higiénico dietéticas.
- Effective diet and exercise interventions to improve boy composition in
obese individuals. Walber Rankin, J. Am J lifestyle Med 9: 48, 2015.
- Resolved: there is sufficient scientific evidence that decreasing sugar
sweetened beverage consumption will reduce the prevalence of obesity and
obesity related diseases. Hu, F. B. Obesity revies 14: 606, 2013.
Estilo de vida.
- Nutrition-education program improves preschoolers at home diet: a group
randomized trial. Williams, P y col. J Acad Nutr Diet 114: 1001, 2014.
- The effect of a lifestyle intervention on metabolic halth in Young
women. Dunn, S y col. Diabetes metaboli Syndrome and obesity targets and
therapy 7: 437, 2014.
Nutrición.
Obesidad.
Prevenciòn sanitaria,
Dislipemias.
Complicaciones
resistencia a la insulina.
·
Obstructive sleep apnoea,
insulin resistance and adipocytokines. Lam, D y col. Clinical Endocrinolgy 82: 165, 2015.
·
Diagnosis and management of
non alchoholic fatty liver disease and related metabolic disorders: consensus
statement from the study group of liver and metabolsim, Chinese society of
endocrinology. Gao, Z y co. Jurnal of
diabetes 5:406, 2013.
·
Nonalcoholic fatty liver
disease and the metabolic syndrome: clinical implications and treatment.
Rahimi, R y co. Nutrition in Clinical practice 28:40, 2013.
Prediabetes.
·
Pharmacological
interventions for preventing or delaying onset of type 2 diabetes mellitus.
Bether, M. A. Diabetes, Obesity and
Metabolism 17: 231, 2015.
Patologías asociadas.
·
Managing
coelic disease in patients with diabetes. Leonard,
M y col. Diabetes, obesity and metabolism 17: 3, 2015.
·
The gluten-free diet and
its current application in celiac disease and dermatitis herpetiformis. Clacci,
C y col. Unite European Gstroenterology J 3:121, 2015.
·
Support for patiens with
celic disease: a literature revies. Ludvigsson, J y col. United European
Gstroenteology J 3: 146, 2015.
·
Screening for celiac
disease in the genral population and in high-risk groups. Ludvigsson, J y col.
United European Gstroenteology J 3: 106, 2015.
Fisiopatologìa.
·
The
immunity diet-microbiota axis in the development of metabolic syndrome.
Brandsma, E y col. Lipidology. 26: 73, apripol 2015.
·
Type 2
diabetes as an inflammatory disease. Donath, M y col. Nature reviess. 11: 98, 2º1.endocrino Nutr
60: 179, 2013.
·
Peripoperative
management of diabetic patients. Aldam, P y col. Br J Anaesth
113:906, 2014.
·
Brown fat
in humnas: consensus points and experimenta guidelines. Cypass, A y col. Cell
metabolism 20:408, 2014.
·
Brown
adipose tissue and its therapeutic potential. Lidell, M y col. J of internal Medicen 276: 364, 2014.
Diabetes
gestacional.
·
Diabees in pregnacncy:
maangement of diabetes and its complications from preconception to the
postnatal period. NICe Guideline. Publishes: 25 February 2015 nice.org.uk/guidance/ng3
Futuro
-
Outpatient glycemic control with a bionic pancreas
in type 1 Diabetes. Russell, S y col. N
Engl 28 June 2014.
Tratamiento
de la diabetes tipo 2.
-
Management
of hyperglycaemia in type 2 diabes, 2014. Statemen position Inzucchi, S y col.
Diabetgologia Doi 101007(a0001125-0|4-2460-0
FUEDIN
Fundación Escuela para la formación y actualización en Diabetes y Nutrición
De Lunes a jueves de 14 a 19 horas. Larrea 1403. P.B. (1117).
Telefax: 4805-7651.
E mail: info@fuedin.org
BIBLIOGRAFIA
CURSO PIE DIABÈTICO.
Fecha de Publicación: 2015-05-22 10:56:34
ver todos los artículos de la categoría
> Bibliografía sugerida ver todos los artículos de la categoría
Para consulta sobre nuestros cursos, seminarios o charlas, puede hacerlo por teléfono al (54 11) 4805-9475 | +54 9 11 6886-5347, por mail a info@fuedin.org, o complete el siguiente formulario.
Fundación Escuela para la formación y actualización en Diabetes y Nutrición
Presidente: Prof. Dr. Adolfo V. Zavala
Fundada en 1993
Ex jefe División Nutrición Hospital de Clínicas “José de San Martín”
Ex jefe Cátedra de Nutrición y Carrera de Especialista en Nutrición. Facultad de Medicina. UBA
Consultorio especializado en Pie Diabético. División Diabetología. Hospital de Clínicas. UBA
TE: (54 11) 4805-9475 | +54 9 11 6886-5347 | info@fuedin.org